Clinical Trial Update: Intravitreous Bevacizumab and Standard Metabolic Control for Diabetic Macular Edema - A Contrast Sensitivity Study [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating intravitreous bevacizumab with standard metabolic control for diabetic macular edema, focusing on contrast sensitivit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: University of Sao Paulo | Conditions: Diabetic Macular Edema | Phase 3 | Status: COMPLETED